🇺🇸 FDA
Pipeline program

CD5CAR-NK cells for refractory invasive mold disease

CD5CAR-NK

Phase 1 other active

Quick answer

CD5CAR-NK cells for refractory invasive mold disease for refractory invasive mold disease is a Phase 1 program (other) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
refractory invasive mold disease
Phase
Phase 1
Modality
other
Status
active

Clinical trials